BioSpace News Archive

Avicanna Inc. is pleased to announce that through its majority owned subsidiary Santa Marta Golden Hemp (“SMGH”) the company has entered into a Master Supply Agreement with established Chilean pharmaceutical company Knop Laboratorios S.A.

Covalon Technologies Ltd. today announced that it has appointed Jason F. Gorel as its interim Chief Financial Officer.

Impact NRS LLC (NRS), the National Institute for Biotechnology in the Negev (NIBN) and the Agricultural Research Organization (ARO) collectively announce the commencement of their partnership through the launch of RumenEra, Inc.

Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to announce that it has received positive feedback from the U.S. Food and Drug Administration (U.S. FDA) at its pre-Investigational New Drug (pre-IND) meeting for its investigation of NP-120 (Ifenprodil) for the treatment of chronic cough.

Eisai announced today the presentation of six abstracts across various gastrointestinal cancers during the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (#GI22).

Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as a distributor of the LuSys Eagle Diagnostics test.